» Articles » PMID: 23785404

MiR-23a Targets Interferon Regulatory Factor 1 and Modulates Cellular Proliferation and Paclitaxel-induced Apoptosis in Gastric Adenocarcinoma Cells

Overview
Journal PLoS One
Date 2013 Jun 21
PMID 23785404
Citations 38
Authors
Affiliations
Soon will be listed here.
Abstract

MicroRNAs are a class of non-coding RNAs that function as key regulators of gene expression at the post-transcriptional level. In our previous research, we found that miR-23a was significantly up-regulated in human gastric adenocarcinoma cells. In the current study, we demonstrate that miR-23a suppresses paclitaxel-induced apoptosis and promotes the cell proliferation and colony formation ability of gastric adenocarcinoma cells. We have identified tumor suppressor interferon regulator factor 1 (IRF1) as a direct target gene of miR-23a. We performed a fluorescent reporter assay to confirm that miR-23a bound to the IRF1 mRNA 3'UTR directly and specifically. The ectopic expression of IRF1 markedly promoted paclitaxel-induced apoptosis and inhibited cell viability and colony formation ability, whereas the knockdown of IRF1 had the opposite effects. The restoration of IRF1 expression counteracted the effects of miR-23a on the paclitaxel-induced apoptosis and cell proliferation of gastric adenocarcinoma cells. Quantitative real-time PCR showed that miR-23a is frequently up-regulated in gastric adenocarcinoma tissues, whereas IRF1 is down-regulated in cancer tissues. Altogether, these results indicate that miR-23a suppresses paclitaxel-induced apoptosis and promotes cell viability and the colony formation ability of gastric adenocarcinoma cells by targeting IRF1 at the post-transcriptional level.

Citing Articles

Global MicroRNA Profiling of HSV-1 Infected Cornea Identifies miR-329 as a Novel Regulator of Virus Infection.

Sharma P, Naqvi R, Borase H, Kapoor D, Valverde A, Capistrano K Invest Ophthalmol Vis Sci. 2025; 66(2):61.

PMID: 39992671 PMC: 11878248. DOI: 10.1167/iovs.66.2.61.


Diagnosis value of miR-181, miR-652, and CA72-4 for gastric cancer.

Tian W, Pang X, Luan F J Clin Lab Anal. 2022; 36(6):e24411.

PMID: 35446997 PMC: 9169223. DOI: 10.1002/jcla.24411.


Long non-coding RNA CERS6-AS1 plays a prognostic role in promoting the progression of gastric cancer.

Li Z, Liu X, Luo N, Pang Y, Hou Y, Jiang G Bioengineered. 2021; 12(2):12931-12939.

PMID: 34852705 PMC: 8809931. DOI: 10.1080/21655979.2021.2012620.


Fluctuating expression of miR-584 in primary and high-grade gastric cancer.

Ghahnavieh L, Tabatabaeian H, Ebrahimi Ghahnavieh Z, Honardoost M, Azadeh M, Moazeni Bistgani M BMC Cancer. 2020; 20(1):621.

PMID: 32615958 PMC: 7345521. DOI: 10.1186/s12885-020-07116-5.


Retraction: miR-23a Targets Interferon Regulatory Factor 1 and Modulates Cellular Proliferation and Paclitaxel-Induced Apoptosis in Gastric Adenocarcinoma Cells.

PLoS One. 2020; 15(5):e0234093.

PMID: 32470092 PMC: 7259545. DOI: 10.1371/journal.pone.0234093.


References
1.
Zhu W, Xu H, Zhu D, Zhi H, Wang T, Wang J . miR-200bc/429 cluster modulates multidrug resistance of human cancer cell lines by targeting BCL2 and XIAP. Cancer Chemother Pharmacol. 2011; 69(3):723-31. DOI: 10.1007/s00280-011-1752-3. View

2.
Liu L, Qiu W, Wang H, Li Y, Zhou J, Xia M . Sublytic C5b-9 complexes induce apoptosis of glomerular mesangial cells in rats with Thy-1 nephritis through role of interferon regulatory factor-1-dependent caspase 8 activation. J Biol Chem. 2012; 287(20):16410-23. PMC: 3351322. DOI: 10.1074/jbc.M111.319566. View

3.
Mandong B, Manasseh A, Tanko M, Echejoh G, Madaki A . Epidemiology of gastric cancer in Jos University Teaching Hospital Jos a 20 year review of cases. Niger J Med. 2011; 19(4):451-4. DOI: 10.4314/njm.v19i4.61975. View

4.
Liu T, Tang H, Lang Y, Liu M, Li X . MicroRNA-27a functions as an oncogene in gastric adenocarcinoma by targeting prohibitin. Cancer Lett. 2008; 273(2):233-42. DOI: 10.1016/j.canlet.2008.08.003. View

5.
Schmittgen T, Livak K . Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc. 2008; 3(6):1101-8. DOI: 10.1038/nprot.2008.73. View